| Characteristics | All () | Male () | Female () | value |
| Abdominal obesity no. (%) | 2421 (72.92%) | 1025 (63.27%) | 1396 (82.12%) | <0.001 | Age (year, ) | | | | <0.001 | Race no. (%) | | | | | White | 2,990 (90.06%) | 1,491 (92.04%) | 1,499 (88.18%) | <0.001 | Black | 253 (7.62%) | 89 (5.49%) | 164 (9.65%) | <0.001 | Other | 67 (2.02%) | 31 (1.91%) | 36 (2.12%) | 0.676 | BMI (kg/m2, ) | | | | | <18.5 | 14 (0.42%) | 9 (0.56%) | 5 (0.29%) | 0.371 | 18.5-24.9 | 409 (12.32%) | 176 (10.86%) | 233 (13.71%) | 0.017 | 25-29.9 | 1,074 (32.35%) | 588 (36.30%) | 486 (28.59%) | <0.001 | ≥ 30.0 | 1,823 (54.91%) | 847 (52.28%) | 976 (57.41%) | 0.003 | Heart rate () | | | | 0.145 | Blood pressure(mm/Hg, ) | | | | | SBP | | | | <0.001 | DBP | | | | 0.010 | NYHA functional classification no. (%) | | | | 0.021 | I and II | 2,250 (67.77%) | 1,129 (69.69%) | 1,121 (65.94%) | | III and IV | 1,070 (32.23%) | 491 (30.31%) | 579 (34.06%) | | Comorbidities no. (%) | | | | | Hypertension | 3,040 (91.57%) | 1,454 (89.75%) | 1,586 (93.29%) | <0.001 | Hospitalization for heart failure | 2,412 (72.65%) | 1,175 (72.53%) | 1,237 (72.76%) | 0.880 | MI | 879 (26.48%) | 554 (34.20%) | 325 (19.12%) | <0.001 | CABG | 428 (12.89%) | 311 (19.20%) | 117 (6.88%) | <0.001 | Diabetes mellitus | 1,068 (32.17%) | 554 (34.20%) | 514 (30.24%) | 0.015 | Dyslipidemia | 2,001 (60.27%) | 1,040 (64.20%) | 961 (56.53%) | <0.001 | COPD | 375 (11.30%) | 229 (14.14%) | 146 (8.59%) | <0.001 | Stroke | 253 (7.62%) | 121 (7.47%) | 132 (7.76%) | 0.748 | Laboratory () | | | | | Creatinine(mg/dL) | | | | <0.001 | eGFR (ml/min/1.73 m2) | | | | <0.001 | Sodium (mmol/L) | | | | 0.050 | Potassium (mmol/L) | | | | 0.020 | ALT (UL) | | | | 0.003 | Glucose (mg/dL) | | | | 0.030 | BNP (pg/ml) | | | | 0.746 | NT-proBNP (pg/ml) | | | | 0.548 | Medications no. (%) | | | | | ACE-I/ARB | 2,807 (84.55%) | 1,369 (84.51%) | 1,438 (84.59%) | 0.981 | Diuretic | 2,704 (81.45%) | 1,300 (80.25%) | 1,404 (82.59%) | 0.089 | Beta-blockers | 2,584 (77.83%) | 1,288 (79.51%) | 1,296 (76.24%) | 0.021 | Aspirin | 2,180 (65.66%) | 1,084 (66.91%) | 1,096 (64.47%) | 0.132 | Statin | 1,724 (51.93%) | 944 (58.27%) | 780 (45.88%) | <0.001 | Calcium channel blocker | 1,242 (37.41%) | 575 (35.49%) | 667 (39.24%) | 0.027 | Hypoglycemic agent | 915 (27.56%) | 480 (29.63%) | 435 (25.59%) | 0.009 | Currently smoke no. (%) | 352 (10.60%) | 260 (16.05%) | 92 (5.41%) | <0.001 | Alcohol drinks in the past weeks no. (%) | | | | | None | 2,595 (78.16%) | 1,104 (68.15%) | 1,491 (87.71%) | <0.001 | 1–4 | 555 (16.72%) | 382 (23.58%) | 173 (10.18%) | <0.001 | 5–10 | 119 (3.58%) | 90 (5.56%) | 29 (1.71%) | <0.001 | >11 | 51 (1.54%) | 44 (2.72%) | 7 (0.41%) | <0.001 | Mean KCCQ overall score () | 54.91 ± 20.36 | 58.53 ± 20.79 | 51.46 ± 19.33 | <0.001 | PHQ no. (%) | | | | 0.231 | <10 | 995 (29.97%) | 539 (33.27%) | 456 (26.82%) | <0.001 | ≥10 | 344 (10.36%) | 171 (10.56%) | 173 (10.18%) | 0.720 |
|
|